157 related articles for article (PubMed ID: 9202270)
1. A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture.
Atkin SL; Green VL; Hipkin LJ; Landolt AM; Foy PM; Jeffreys RV; White MC
J Neurosurg; 1997 Jul; 87(1):85-8. PubMed ID: 9202270
[TBL] [Abstract][Full Text] [Related]
2. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
3. The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas.
Ekramullah SM; Saitoh Y; Arita N; Ohnishi T; Hayakawa T
Acta Neurochir (Wien); 1996; 138(12):1449-55. PubMed ID: 9030353
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas.
van Rijn SJ; Grinwis GC; Penning LC; Meij BP
Domest Anim Endocrinol; 2010 May; 38(4):244-52. PubMed ID: 20022446
[TBL] [Abstract][Full Text] [Related]
5. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.
Shibuya M; Saito F; Miwa T; Davis RL; Wilson CB; Hoshino T
Acta Neuropathol; 1992; 84(2):178-83. PubMed ID: 1381860
[TBL] [Abstract][Full Text] [Related]
6. Proliferation markers in different types of clinically non-secreting pituitary adenomas.
Schreiber S; Saeger W; Lüdecke DK
Pituitary; 1999 May; 1(3-4):213-20. PubMed ID: 11081200
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.
Mastronardi L; Guiducci A; Puzzilli F
BMC Cancer; 2001; 1():12. PubMed ID: 11570981
[TBL] [Abstract][Full Text] [Related]
8. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
Lath R; Chacko G; Chandy MJ
Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
[TBL] [Abstract][Full Text] [Related]
9. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA.
Winczyk K; Pawlikowski M
Folia Histochem Cytobiol; 2005; 43(3):137-41. PubMed ID: 16201313
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma.
Pawlikowski M; Gruszka A; Kurnatowska I; Winczyk K; Kunert-Radek J; Radek A
Folia Histochem Cytobiol; 2006; 44(1):37-41. PubMed ID: 16584090
[TBL] [Abstract][Full Text] [Related]
12. Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.
de Aguiar PH; Aires R; Laws ER; Isolan GR; Logullo A; Patil C; Katznelson L
Neurol Res; 2010 Dec; 32(10):1060-71. PubMed ID: 20483025
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
[TBL] [Abstract][Full Text] [Related]
14. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence.
Hsu DW; Hakim F; Biller BM; de la Monte S; Zervas NT; Klibanski A; Hedley-Whyte ET
J Neurosurg; 1993 May; 78(5):753-61. PubMed ID: 8096873
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas.
Grimm F; Maurus R; Beschorner R; Naros G; Stanojevic M; Gugel I; Giese S; Bier G; Bender B; Honegger J
Acta Neurochir (Wien); 2019 Jun; 161(6):1149-1156. PubMed ID: 31037500
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of insulin-like growth factor 1 on the hormonal product and proliferation of glycoprotein-secreting human pituitary adenomas.
Atkin SL; Landolt AM; Jeffreys RV; Hipkin L; Radcliffe J; Squire CR; White MC
J Clin Endocrinol Metab; 1993 Oct; 77(4):1059-66. PubMed ID: 7691862
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenomas. Correlation of the cytologic appearance with biologic behavior.
Pegolo G; Buckwalter JG; Weiss MH; Hinton DR
Acta Cytol; 1995; 39(5):887-92. PubMed ID: 7571965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
